Avraham Karasik

Medicine & Life Sciences

1. Acarbose 25%
2. Annexin A1 15%
3. Aurintricarboxylic Acid 34%
4. Cardiovascular Diseases 24%
5. Cell Death 14%
6. Chronic Renal Insufficiency 18%
7. Cohort Studies 15%
8. Diabetes Mellitus 14%
9. Dipeptidyl-Peptidase IV Inhibitors 35%
10. empagliflozin 15%
11. Epidermal Growth Factor 27%
12. ErbB Receptors 15%
13. Fasting 15%
14. Follicle Stimulating Hormone 14%
15. Glucose 46%
16. Glucose Intolerance 44%
17. Granulosa Cells 14%
18. Heart Failure 21%
19. Hepatocytes 16%
20. Hyperinsulinism 15%
21. Hypertension 17%
22. Insulin 69%
23. insulin degludec 14%
24. Insulin Receptor 37%
25. Insulin Receptor Substrate Proteins 26%
26. Insulin Resistance 18%
27. Insulin-Like Growth Factor Binding Protein 2 26%
28. Insulin-Like Growth Factor Binding Protein 3 26%
29. Insulin-Like Growth Factor Binding Proteins 15%
30. Insulin-Like Growth Factor I 53%
31. Israel 49%
32. Kidney 20%
33. Laron Syndrome 16%
34. Liraglutide 25%
35. Liver 15%
36. MCF-7 Cells 17%
37. Metformin 15%
38. Phosphorylation 46%
39. Population 14%
40. Proteins 18%
41. Serine 20%
42. Serum 17%
43. Sitagliptin Phosphate 19%
44. Sodium-Glucose Transport Proteins 20%
45. Sodium-Glucose Transporter 2 Inhibitors 19%
46. Somatomedins 35%
47. Therapeutics 14%
48. Tumor Necrosis Factor-alpha 14%
49. Type 2 Diabetes Mellitus 100%
50. Tyrosine 30%